Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Eun Ji Shin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0624-8149; OpenAlex author ID A5039431392. Sources: OpenAlex.

Their work

Papers
26 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
103
Papers, trials and grants by year

2012: 2 papers · 2013: 2 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: 3 papers · 2018: 4 papers · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: 6 papers · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 26

  1. Association of obstructive sleep apnea with pancreatic cancer in high-risk patients under surveillance in CAPS and PCYST cohorts. Co-author DOI 10.1016/j.pan.2026.10.013↗
  2. Pancreatic Cancer Surveillance and Survival of High-Risk Individuals. Co-author DOI 10.1001/jamaoncol.2024.1930↗
  3. A Multi-Institutional Safety and Feasibility Study Exploring the Use of Hydrogel to Create Spatial Separation between the Pancreas and Duodenum in Patients wit… Co-author DOI 10.1016/j.prro.2023.11.011↗
  4. Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therapy and prognosis in pancreatic cancer. Co-author DOI 10.1097/js9.0000000000000200↗
  5. Association of Matrix Metalloproteinase 7 Expression With Pathologic Response After Neoadjuvant Treatment in Patients With Resected Pancreatic Ductal Adenocarc… Co-author DOI 10.1001/jamasurg.2022.1362↗
  6. Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer. Co-author DOI 10.1016/j.cgh.2020.11.006↗
  7. The Impact of the COVID-19 Pandemic on Multidisciplinary Clinics: A High-Volume Pancreatic Cancer Center Experience. Co-author DOI 10.1067/j.cpradiol.2022.05.001↗
  8. RAD51B Harbors Germline Mutations Associated With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1200/po.21.00404↗
  9. Finite Element-Based Personalized Simulation of Duodenal Hydrogel Spacer: Spacer Location Dependent Duodenal Sparing and a Decision Support System for Spacer-E… Co-author DOI 10.3389/fonc.2022.833231↗
  10. Endoscopic ultrasound guided interventions in the management of pancreatic cancer. First author DOI 10.4253/wjge.v14.i4.191↗
  11. Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017. Co-author DOI 10.1016/j.canlet.2020.10.039↗
  12. The Feasibility of Haar Feature-Based Endoscopic Ultrasound Probe Tracking for Implanting Hydrogel Spacer in Radiation Therapy for Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.759811↗
  13. Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer. Co-author DOI 10.1007/s11605-019-04230-z↗
  14. Evaluation of a Novel Absorbable Radiopaque Hydrogel in Patients Undergoing Image Guided Radiation Therapy for Borderline Resectable and Locally Advanced Pancr… First author DOI 10.1016/j.prro.2020.01.013↗
  15. Demonstration of Safety and Feasibility of Hydrogel Marking of the Pancreas-Duodenum Interface for Image Guided Radiation Therapy (IGRT) in a Porcine Model: Im… First author DOI 10.1016/j.ijrobp.2018.02.024↗
  16. Dose Prediction Model for Duodenum Sparing With a Biodegradable Hydrogel Spacer for Pancreatic Cancer Radiation Therapy. Co-author DOI 10.1016/j.ijrobp.2018.07.184↗
  17. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. Co-author DOI 10.1053/j.gastro.2018.05.035↗
  18. Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients. Co-author DOI 10.18632/oncotarget.24713↗
  19. A Novel Absorbable Radiopaque Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum in Radiation Therapy for Pancreatic Cancer. Co-author DOI 10.1016/j.ijrobp.2017.08.006↗
  20. Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cance… Co-author DOI 10.1136/gutjnl-2015-311166↗
  21. A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review. Co-author DOI 10.18632/oncotarget.18458↗
  22. Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management. Co-author DOI 10.1097/sla.0000000000001156↗
  23. The role of endoscopy in the treatment, management, and personalization of pancreatic cancer. Co-author DOI 10.1016/j.currproblcancer.2013.10.007↗
  24. Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality ther… Co-author DOI 10.3978/j.issn.2078-6891.2013.044↗
  25. Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy. Co-author DOI 10.1016/j.gie.2012.07.006↗
  26. Pancreatic cancer screening. Co-author DOI 10.1016/j.gtc.2011.12.001↗

Closest collaborators

The 25 strongest of 103 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Amol Kumar Narang · 12 shared papers, 2017–2024 · strength 1.23
  2. Jin Peng He · 10 shared papers, 2016–2024 · strength 1.01
  3. Marcia Irene Canto · 8 shared papers, 2012–2026 · strength 0.87
  4. Kai Ding · 7 shared papers, 2017–2024 · strength 0.80
  5. Michael Goggins · 6 shared papers, 2017–2026 · strength 0.78
  6. Anne Marie Lennon · 9 shared papers, 2012–2024 · strength 0.78
  7. Richard Andrew Burkhart · 7 shared papers, 2020–2024 · strength 0.77
  8. Elliot K. Fishman · 8 shared papers, 2017–2024 · strength 0.77
  9. Joseph M. Herman · 10 shared papers, 2012–2024 · strength 0.74
  10. Ralph H. Hruban · 9 shared papers, 2016–2024 · strength 0.73
  11. Amanda L. Blackford · 4 shared papers, 2018–2026 · strength 0.57
  12. Christopher Lee Wolfgang · 7 shared papers, 2013–2022 · strength 0.54
  13. Lei Zheng · 6 shared papers, 2013–2023 · strength 0.53
  14. Ammar A. Javed · 5 shared papers, 2020–2022 · strength 0.51
  15. Tossapol Kerdsirichairat · 3 shared papers, 2020–2022 · strength 0.51
  16. Jun Yu · 5 shared papers, 2017–2023 · strength 0.51
  17. Alison P. Klein · 5 shared papers, 2018–2024 · strength 0.50
  18. Daniel A. Laheru · 6 shared papers, 2013–2022 · strength 0.45
  19. Avani Dholakia Rao · 5 shared papers, 2017–2022 · strength 0.44
  20. Matthew John Weiss · 6 shared papers, 2016–2021 · strength 0.43
  21. William R. Burns · 4 shared papers, 2021–2023 · strength 0.43
  22. Kelly J. Lafaro · 3 shared papers, 2022–2023 · strength 0.38
  23. Joseph R. Habib · 3 shared papers, 2022–2023 · strength 0.38
  24. Benedict Kinny‐Köster · 3 shared papers, 2022–2023 · strength 0.38
  25. Atif Zaheer · 4 shared papers, 2020–2022 · strength 0.38

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.